Tubeless Insulin Pump Market Size By Component (Pod/Patch, Remote), By Distribution Channel (Hospitals, Pharmacies, E-commerce), Industry Analysis Report, Country Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Sep 2019  |  Report ID: GMI2032  |  Authors: Sumant Ugalmugale

Report Format: PDF   |   Pages: 95   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Tubeless Insulin Pump Market size was valued at USD 549.6 million in 2018 and is expected to witness growth of over 24.0% CAGR from 2019 to 2025.
 

Germany Tubeless Insulin Pump Market, By Component, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

With mounting cases of diabetes, especially among geriatric patients, the tubeless insulin pump market is estimated to witness significant growth over the upcoming years. According to National Diabetes Statistics, approximately 30.3 million people suffered from diabetes across the U.S. in the year 2015. Rising prevalence of diabetes will accelerate the adoption rate of tubeless insulin pump systems for better care and management of disease. Development of novel insulin delivery devices will further boost the market growth. Lightweight and disposable pod such as Omnipod, by Ypsomed, continuously delivers insulin for upto three days and is associated with a remote to determine insulin delivery intervals. Similarly, in March 2019, the U.S. FDA gave fast-track designation to EoPancreas, an Automated Insulin Delivery (AID) system, by EoFlow. The device is an innovative closed-loop system for insulin delivery. Such breakthroughs and expanding treatment approvals for effective management of diabetes will augment the global tubeless insulin pump industry growth.
 

Increasing government initiatives and rising awareness about diabetes will positively influence the market growth over upcoming years. For instance, the Australian Ministry of Health funded 100 million for extending promotional activity of insulin, in year 2018. The initiative provides fully subsidized insulin monitor device to patients age below 21 years of age that are affected with diabetes. Hence, increasing government initiatives and diabetes care awareness among patients will upsurge demand for tubeless insulin pump market growth in forthcoming years.
 

However, limited reimbursement for tubeless insulin pump and significantly increasing cost of insulin delivery systems may hamper the market growth in upcoming years.
 

Tubeless Insulin Pump Market Report Coverage
Report Coverage Details
Base Year: 2018
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Pages: 95 Tables, Charts & Figures: 62
Geographies covered (16): U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia
Segments covered: Component, Distribution Channel and Region
Companies covered (10): Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc, Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Abbott Diabetes Care

Request 15% Free Customization on this Report
 

By Component

Pod/patch tubeless insulin pump market accounted for market size of USD 334.5 million in 2018. Pod/patch is enabled with insulin reservoirs and insulin insertion set for topical distribution. Emerging firms are innovating such insulin delivery devices with advancements such as Bluetooth-enabled devices, wearables, closed-loop systems among others. Furthermore, rising adoption of pod/patch for convenient handling and easy administration of insulin at appropriate time intervals will lead to greater demand over the forthcoming years.
 

Remote tubeless insulin pump market is forecast to progress at 24.6% CAGR during the analysis period. Growing adoption of remote tubeless insulin pump for avoiding painless procedure and enhanced convenience in insulin delivery will highly impact the adoption rate of remote tubeless insulin pump devices in the upcoming years. Also, increasing number of admissions in healthcare facilities will result into greater adoption of remote tubeless insulin pumps to prevent diabetic nephropathy and neuropathy. With increasing number of patients suffering from type 1 diabetes, remote tubeless insulin pump market growth will spur over the foreseeable future.
 

By Distribution Channel

U.S. Tubeless Insulin Pump Market Size, By Distribution Channel, 2018 (USD Million)
U.S. Tubeless Insulin Pump Market Size, By Distribution Channel, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF

 

Pharmacies distribution segment is estimated to progress at more than 24.0% CAGR during projected timeframe. Expanding number of pharmacies, greater accessibility coupled with increasing need for tubeless insulin pumps will augment the segmental size in forecast years. Need for accurately measuring and controlling blood glucose and insulin levels majorly impacts the demand for tubeless insulin pumps. Rising prevalence of diabetes will further impel the demand for tubeless insulin pump in pharmacies. In addition, availability of p advanced diabetes management devices in pharmacies will positively influence the segmental growth over upcoming years.
 

E-commerce distribution channel segment held over USD 370.0 million market size in 2018 and is estimated to witness momentous growth over forecast period. Online product distribution offers several alternatives to the diabetic patients to choose among a broad range of diabetes management products. E-commerce holds robust growth potential with increasing internet penetration and growing number of internet users, thereby impelling the segmental growth in untapped geographies, over upcoming years. 
 

By Region

Europe Tubeless Insulin Pump Market Size, By Country, 2025 (USD Million)
Europe Tubeless Insulin Pump Market Size, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Canada market held revenue share of more than 10% in 2018. Rising population base suffering from diabetes as well as increasing expenditure on insulin uptake per person will highly impact the demand for tubeless insulin pump industry in the country. According to Canada Statistics, around 2.3 million Canadians, aged 12 years and above were diagnosed with diabetes in 2017. In addition, new product launch and continuous upgradation in technology will expand Canada market growth in the foreseeable future.
 

India market is projected to progress at 22.7% CAGR during the estimation timeframe. According to the International Diabetes Federation, more than 72 million people suffered from diabetes in 2017 across India. Increasing number of patients and government expenditure and awareness initiatives for effective management of diabetes in the country will serve to be a high impacting factor for the market growth. Moreover, upsurge in the demand for insulin delivery devices in rural areas, growing healthcare infrastructure and introduction of newer technologies will spur India tubeless insulin pump business growth in the future years.   
 

Competitive Market Share

Few of the key industry players are Medtrum Technologies, Cellnova, Roche, Spring Health Solutions, Debiotech among other players. Product advancement through addition of new features, collaborations and mergers are some of the major strategies undertaken by these firms to consolidate their market position.
 

Recent industry developments:

  • In April 2019, Omnipod DASH announced about its launch of Omnipod DASH in the U.S. The device is enabled with Bluetooth wireless technology, meter integration, diabetes management app integrations, personal diabetes manager, new pods among various other features for accurate administration of insulin in the body, thereby fortifying the company’s portfolio.
  •  
  • In July 2018, CeQur acquired Calibra Medical. The acquisition was aimed at developing and manufacturing technologically advanced wearable insulin device for increasing product portfolio and bringing technologically advanced product in market.
     

Industry Background

The first insulin pump was discovered in 1970’s by the name of Biostator. Before the advent of insulin pumps, injection therapy was the used to deliver insulin in human body. Over the years, the insulin pump industry went through several technological advancements that lead to launch of several glucose monitoring devices and self-monitoring blood glucose meters. Similarly, continuous insulin administration devices were introduced in early 2000’s for avoiding painless procedures and accurate dosing of insulin. Thus, continuous product improvement along with growing number of diabetes patients will boost tubeless insulin pump industry growth in the foreseeable future.


Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X